Scoring system evaluation for orbital exenteration in patients with rhino-orbito-cerebral mucormycosis

J Fr Ophtalmol. 2022 Jan;45(1):47-52. doi: 10.1016/j.jfo.2021.07.008. Epub 2021 Nov 22.

Abstract

Purpose: To evaluate our patients with rhino-orbito-cerebral mucormycosis according to a new scoring system and to compare those who underwent orbital exenteration persuant to a new threshhold.

Methods: Mucormycosis is a fungal disease that can be of acute onset, aggressive, and angioinvasive. Aggressive surgical debridement, long-term systemic antifungal therapy, and treatment of underlying predisposing factors are essential to the treatment. However, orbital exenteration is a very difficult decision to make, particularly in patients with orbital involvement, because there is little information in the literature, resulting in limited support for making this aggressive surgical decision. In this study, our 43 cases of mucormycosis were evaluated in terms of orbital exenteration using a scoring system (including clinical signs and symptoms, ophthalmoscopic findings, and radiologic results) developed by Shah et al., which establishes indications for orbital exenteration in mucormycosis.

Results: According to our study, if the threshold score for exenteration is 19.0, the sensitivity was 100% and specificity was 97%, providing better results than the 23.0 threshold score determined by the reference study for exenteration. When these two score thresholds were compared, there was a statistically significant difference.

Conclusion: We believe that this scoring system may be beneficial to use for orbital exenteration in patients with mucormycosis. Prospective studies in large case series are required to determine the most appropriate threshold score.

Keywords: Exenteration; Exentération; Mucormycose; Mucormycosis; Scoring system; Système de notation.

MeSH terms

  • Antifungal Agents / therapeutic use
  • Eye Infections, Fungal* / diagnosis
  • Eye Infections, Fungal* / surgery
  • Humans
  • Mucormycosis* / diagnosis
  • Mucormycosis* / surgery
  • Orbit Evisceration
  • Orbital Diseases* / diagnosis
  • Orbital Diseases* / drug therapy
  • Orbital Diseases* / surgery
  • Prospective Studies

Substances

  • Antifungal Agents